Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010
NCT00945841
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
126
Enrollment
INDUSTRY
Sponsor class
Conditions
Seasonal Influenza
Interventions
BIOLOGICAL:
inactivated split influenza vaccine
Sponsor
Novartis
Collaborators
[object Object]